Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients
Authors:
- Antti J. HakanenAHAntti J. Hakanen
- Pirkko KotilainenPKPirkko Kotilainen
- Susa PitkänenSPSusa Pitkänen
- Solja HuikkoSHSolja Huikko
- Anja SiitonenASAnja Siitonen
- Pentti HuovinenPHPentti Huovinen
Open Access
- 25 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (3) , 569-572
Abstract
Objectives: The proportion of Salmonella isolates with reduced susceptibility to fluoroquinolones has increased during recent years in many countries, especially in South-east Asia. The present study was performed to evaluate the incidence of and changes in quinolone resistance in Salmonella isolates of either foreign or domestic origin in Finland. Methods: A total of 1004 Salmonella isolates collected from Finnish patients between 2000 and 2004 were analysed for ciprofloxacin susceptibility. Of these isolates, 504 were of domestic origin and 500 were of foreign origin, collected from travellers to 43 different countries. The Salmonella collection consisted of 89 different serotypes. All isolates belonged to non-typhoidal Salmonella enterica. Results: Of all isolates, 3 (0.3%) were ciprofloxacin-resistant (MIC ≥ 4 mg/L) and 214 (21.3%) exhibited reduced susceptibility to ciprofloxacin (MIC ≥ 0.125–2 mg/L). The annual proportion of reduced susceptibility varied between 3 and 15% among the domestic Salmonella isolates (P = 0.123). Between 2000 and 2004, the annual proportion of reduced susceptibility increased significantly (from 23 to 39%; P = 0.001) among all foreign isolates as well as among those from Spain alone (from 4 to 73%; P < 0.001). Among the isolates from Thailand, reduced ciprofloxacin susceptibility remained at a constantly high level (52–66%) throughout the study. Conclusions: Our results show that reduced fluoroquinolone susceptibility in S. enterica is not restricted to South-east Asia alone but continues to grow rapidly in many parts of the world including countries of the European Union.Keywords
This publication has 11 references indexed in Scilit:
- Clonal Expansion May Account for High Levels of Quinolone Resistance in Salmonella enterica Serovar EnteritidisApplied and Environmental Microbiology, 2005
- Characterization of Salmonella spp. Mutants with Reduced Fluoroquinolone Susceptibility: Importance of Efflux Pump MechanismsChemotherapy, 2005
- Fluoroquinolone Resistance inCampylobacter jejuniIsolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel DestinationEmerging Infectious Diseases, 2003
- Excess Mortality Associated with Antimicrobial Drug-ResistantSalmonellaTyphimuriumEmerging Infectious Diseases, 2002
- Reduced Fluoroquinolone Susceptibility in Salmonella enterica Serotypes in Travelers Returning from Southeast AsiaEmerging Infectious Diseases, 2001
- Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human IsolatesEmerging Infectious Diseases, 2001
- An Outbreak of Multidrug-Resistant, Quinolone-ResistantSalmonella entericaSerotype Typhimurium DT104New England Journal of Medicine, 1999
- Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995–1997Journal of Antimicrobial Chemotherapy, 1999
- Increasing spectrum of resistance in multiresistant Salmonella typhimuriumThe Lancet, 1996
- Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patientsAntimicrobial Agents and Chemotherapy, 1993